Trial Profile
Oral versus intravenous proton-pump inhibitors following successful endoscopic treatment in patients with high-risk bleeding peptic ulcers
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 May 2011
Price :
$35
*
At a glance
- Drugs Esomeprazole (Primary) ; Esomeprazole (Primary) ; Lansoprazole
- Indications Gastrointestinal haemorrhage
- Focus Therapeutic Use
- 21 May 2011 New trial record
- 10 May 2011 Results presented at Digestive Disease Week 2011.